[1] Hong SB, Choi SH, Kim KW, et al. Diagnostic performance of FDG-PET/MRI for liver metastasis in patients with primary malignancy: a systematic review and meta-analysis. Eur Radiol, 2019, 29(7):3553-3563.
[2] Ko Y, Kim J, Park JK, et al. Limited detection of small (≤ 10 mm) colorectal liver metastasis at preoperative CT in patients undergoing liver resection. PLoS One, 2017, 12(12):e0189797.
[3] Dong Y, Zhang XL, Mao F, et al.Contrast-enhanced ultrasound features of histologically proven small (≤20 mm) liver metastases. Scand J Gastroenterol, 2017, 52(1):23-28.
[4] Kaifi JT, Kunkel M, Dicker DT, et al. Circulating tumor cell levels are elevated in colorectal cancer patients with high tumor burden in the liver. Cancer Biol Ther, 2015, 16(5):690-698.
[5] Obayashi J, Kawaguchi K, Manabe S, et al. Prognostic factors indicating survival with native liver after Kasai procedure for biliary atresia. Pediatr Surg Int, 2017, 33(10):1047-1052.
[6] Hara Y, Ogata Y, Shirouzu K. Early tumor growth in metastatic organs influenced by the microenvironment is an important factor which provides organ specificity of colon cancer metastasis. J Exp Clin Cancer Res, 2000, 19(4):497-504.
[7] Banerji A, Naish JH, Watson Y, et al. DCE-MRI model selection for investigating disruption of microvascular function in livers with metastatic disease. J Magn Reson Imaging, 2012, 35(1):196-203.
[8] Van der Pompe WB, Cox PH, Treurniet-Donker AD, et al. The correlation between liver scintigraphy and serum CEA levels in the detection of liver metastases from rectum carcinoma. A retrospective study. Eur J Nucl Med, 1976, 1(3):141-143.
[9] Gabata T, Matsui O, Kadoya M, et al. Delayed MR imaging of the liver: correlation of delayed enhancement of hepatic tumors and pathologic appearance. Abdom Imaging, 1998, 23(3):309-313.
[10] Vialle R, Boucebci S, Richer JP, et al. Preoperative detection of hepatic metastases from colorectal cancer: Prospective comparison of contrast-enhanced ultrasound and multidetector-row computed tomography (MDCT). Diagn Interv Imaging, 2016, 97(9):851-855.
[11] Mishima M, Toh U, Iwakuma N, et al. Evaluation of contrast Sonazoid-enhanced ultrasonography for the detection of hepatic metastases in breast cancer. Breast Cancer, 2016, 23(2):231-241.
[12] Sivesgaard K, Larsen LP, Srensen M, et al. Diagnostic accuracy of CE-CT, MRI and FDG PET/CT for detecting colorectal cancer liver metastases in patients considered eligible for hepatic resection and/or local ablation. Eur Radiol, 2018, 28(11):4735-4747.
[13] Dnil M, Popescu A, Sirli R, et al. Contrast enhanced ultrasound (CEUS) in the evaluation of liver metastases. Med Ultrason, 2010, 12:233-237.
[14] Murphy-Lavallee J, Jang HJ, Kim TK, et al. Are metastases really hypovascular in the arterial phase? The perspective based on contrast-enhanced ultrasonography. J Ultrasound Med, 2007, 26:1545-1556.
[15] Claudon M, Dietrich CF, Choi BI, et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver-update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultrasound Med Biol, 2013, 39:187-210.
[16] Loria F, Loria G, Basile S, et al. Contrastenhanced ultrasound of hepatocellular carcinoma: correlation between enhancement pattern and cellular differentiation on histopathlogy. Updates Surg, 2012, 64:247-255.
[17] Kong WT, Wang WP, Huang BJ, et al. Value of wash-in and wash-out time in the diagnosis between hepatocellular carcinoma and other hepatic nodules with similar vascular pattern on contrast-enhancedultrasound. J Gastroenterol Hepatol, 2014, 29: 576-580.
[18] Kong WT, Ji ZB, Wang WP, et al. Evaluation of liver metastases using contrast-enhanced ultrasound: Enhancement patterns and influencing factors. Gut Liver, 2016, 10(2):283-287.
[19] Wu W, Chen MH, Sun M, et al. Contrast-enhanced ultrasound of hepatocarcinogenesis in liver cirrhosis. Chin Med J (Engl), 2012, 125(17):3104-3109.
[20] Strobel D, Seitz K, Blank W, et al. Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1,349 liver lesions in contrast-enhanced ultrasound (CEUS). Ultraschall Med, 2009, 30(4):376-382. |